Manulife (Manufacturers Life Insurance)
VBIV

Manulife (Manufacturers Life Insurance)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,177
Closed -$10.7K – 3083
2023
Q1 		$10.7K Hold
1,177
– – ﹤0.01% 2923
2022
Q4 		$13.8K Hold
1,177
– – ﹤0.01% 2954
2022
Q3 		$24.9K Buy
+1,177
New +$31.7K ﹤0.01% 2940
2022
Q2 		– Sell
-2,604
Closed -$130K – 3182
2022
Q1 		$130K Sell
2,604
-727
-22% -$35.9K ﹤0.01% 2911
2021
Q4 		$234 Buy
3,331
+47
+1% +$3.96K ﹤0.01% 2797
2021
Q3 		$286K Sell
3,284
-205
-6% -$19.5K ﹤0.01% 2712
2021
Q2 		$351K Buy
3,489
+149
+4% +$14.5K ﹤0.01% 2695
2021
Q1 		$312K Sell
3,340
-199
-6% -$20.2K ﹤0.01% 2593
2020
Q4 		$292K Buy
3,539
+294
+9% +$25.1K ﹤0.01% 2530
2020
Q3 		$278K Sell
3,245
-95
-3% -$11.1K ﹤0.01% 2343
2020
Q2 		$314K Buy
3,340
+31
+0.9% +$1.71K ﹤0.01% 2224
2020
Q1 		$94K Buy
+3,309
New +$129K ﹤0.01% 2593
2018
Q2 		– Sell
-636
Closed -$66K – 4397
2018
Q1 		$66K Sell
636
-348
-35% -$41.5K ﹤0.01% 3501
2017
Q4 		$126K Buy
+984
New +$121K ﹤0.01% 3321

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VBIV Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 1,177 shares — an estimated $10.7K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VBIV in Q4 2017 and held it in 14 quarters. The position peaked at $351K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,177 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $10.7K.
  • Manulife (Manufacturers Life Insurance) first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $351K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.